Brokerages Set LifeStance Health Group, Inc. (NASDAQ:LFST) Price Target at $8.83

LifeStance Health Group, Inc. (NASDAQ:LFST) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, five have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $8.8333.

LFST has been the topic of several analyst reports. Barclays assumed coverage on LifeStance Health Group in a research note on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 target price on the stock. BMO Capital Markets began coverage on shares of LifeStance Health Group in a research note on Thursday, November 13th. They set an “outperform” rating and a $8.00 price objective for the company. Wall Street Zen downgraded shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings restated a “sell (d-)” rating on shares of LifeStance Health Group in a research note on Monday, December 29th. Finally, UBS Group increased their price target on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Friday, November 7th.

LifeStance Health Group Stock Performance

Shares of NASDAQ:LFST opened at $7.07 on Wednesday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58. The firm’s 50 day simple moving average is $6.97 and its 200-day simple moving average is $5.80. The firm has a market cap of $2.75 billion, a PE ratio of -235.67 and a beta of 1.12. LifeStance Health Group has a one year low of $3.74 and a one year high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The business had revenue of $363.81 million for the quarter, compared to the consensus estimate of $355.06 million. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.The business’s revenue was up 16.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.02) EPS. As a group, equities analysts predict that LifeStance Health Group will post -0.18 EPS for the current year.

Insider Activity

In other LifeStance Health Group news, Director Robert Bessler sold 119,942 shares of LifeStance Health Group stock in a transaction on Friday, December 19th. The shares were sold at an average price of $7.04, for a total transaction of $844,391.68. Following the sale, the director owned 1,318,983 shares of the company’s stock, valued at $9,285,640.32. The trade was a 8.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Lisa K. Miller sold 57,240 shares of the business’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider owned 261,292 shares in the company, valued at $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 327,326 shares of company stock worth $2,259,317 over the last 90 days. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of LifeStance Health Group

Several institutional investors have recently made changes to their positions in the company. Bayesian Capital Management LP acquired a new stake in LifeStance Health Group during the second quarter worth $52,000. Park Edge Advisors LLC grew its stake in shares of LifeStance Health Group by 14.4% in the fourth quarter. Park Edge Advisors LLC now owns 11,863 shares of the company’s stock worth $84,000 after acquiring an additional 1,495 shares in the last quarter. Vanguard Personalized Indexing Management LLC acquired a new position in LifeStance Health Group during the 3rd quarter worth $72,000. Blair William & Co. IL acquired a new position in shares of LifeStance Health Group during the second quarter worth about $70,000. Finally, Public Employees Retirement System of Ohio acquired a new position in LifeStance Health Group during the 2nd quarter worth approximately $70,000. Hedge funds and other institutional investors own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.